Kincell Bio’s mission is to help innovators transform promising cell therapy discoveries into commercially available treatments for patients. By combining deep scientific expertise, uncompromising quality, and collaborative partnership, we support programs from early development through clinical and commercial manufacturing, advancing therapies cell by cell toward a healthier world.
We deliver right-first-time execution to ensure compliance, consistency, and readiness for pivotal and commercial success.
We apply deep cell therapy expertise and industry-leading capabilities to drive smarter, faster process development, analytics, and manufacturing.
We follow through on our commitments with dependable execution across the product lifecycle—ensuring on-time delivery and sustained attention to every program.
We act as a true extension of your team, providing proactive collaboration, transparent communication, and tailored support that adapts to your evolving needs.
Our purpose-built U.S. facilities are designed to grow with you—from early development through commercial launch—offering the right-sized support and flexibility at every stage.
Reliable supply begins with uncompromising quality and disciplined execution. Our teams generate the robust data, processes, and controls innovators need to understand their therapies and advance confidently through the phases of development. Purpose-built U.S. facilities provide right-sized capacity that scales with each program, from early clinical manufacturing to pivotal studies and commercial supply, ensuring dependable delivery, scientific rigor, and scalable supply for patients awaiting these life-changing therapies.
Scientific rigor guides every decision our team makes. Kincell Bio’s CMC development, analytics, manufacturing, and quality experts work together to design smarter processes and generate the data innovators need to move forward with confidence. By combining deep cell therapy expertise with advanced technologies and continuous process improvement, we help clients refine their programs, reduce risk, and deliver high-quality therapies to patients faster.
Partnership means working side by side with our clients to advance their programs with clarity and confidence. We collaborate closely to understand each innovator’s goals, whether speed, flexibility, or cost, and tailor our approach accordingly. Through transparent communication, thoughtful planning, and shared problem-solving, we act as a true extension of our partners’ teams, helping them mitigate risk, refine their processes, and move their therapies toward patients with reliability and purpose.
From early-phase process and analytical development in Gainesville to late-stage and commercial manufacturing in Research Triangle Park, Kincell Bio supports cell therapy programs across their full lifecycle. In this video, hear how Kincell Bio’s team balances speed, quality, and collaboration, from pre-IND development to the moment a patient is waiting at the hospital.
Quality is not merely a department at Kincell; it is a mindset that runs from the shop floor to the highest levels of the organization. The Kincell Bio team shares how they approach their work, knowing that behind every batch is a patient, and a quality therapeutic is the promise they make to that patient.
Kincell provides support across the full cell therapy lifecycle, with our Gainesville, FL, USA facility focused on early CMC and clinical supply, and our Research Triangle Park, NC, USA facility emphasizing pivotal and commercial manufacturing. Together, the two facilities provide scalable and redundant GMP capacity, robust analytics, and expansion-ready infrastructure to ensure long-term program continuity and supply reliability.
Kincell Bio develops and delivers tomorrow’s cell therapy cures by integrating comprehensive, end-to-end capabilities across the full product lifecycle, with deep expertise spanning a broad range of autologous and allogeneic cell therapy modalities.
Integrated Services
The Cornerstones of Cell Therapy Excellence, explores analytical, process development, quality, and manufacturing approaches that enable sustainable progress from early development through...
In our new eBook, Navigating Intensifying Cell Therapy Regulatory Expectations, Kincell Bio’s scientific and executive leadership break down what’s changed, why programs...
This webinar explores how integrated PD/AD expertise can deliver robust, regulatory-ready assays and accelerates cell therapy development.
Talk to an expert
Leveraging our science-first expertise and right-first-time quality, partner with Kincell Bio to advance your cell therapy from concept to commercialization.
"*" indicates required fields
